Literature DB >> 23904554

Reversibility of the monocrotaline pulmonary hypertension rat model.

Gerrina Ruiter, Frances S de Man, Ingrid Schalij, Shellice Sairras, Katrien Grünberg, Nico Westerhof, Willem J van der Laarse, Anton Vonk-Noordegraaf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23904554     DOI： 10.1183/09031936.00012313

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

1.  Cellular senescence impairs the reversibility of pulmonary arterial hypertension.

Authors:  Diederik E van der Feen; Guido P L Bossers; Quint A J Hagdorn; Jan-Renier Moonen; Kondababu Kurakula; Robert Szulcek; James Chappell; Francesco Vallania; Michele Donato; Klaas Kok; Jaskaren S Kohli; Arjen H Petersen; Tom van Leusden; Marco Demaria; Marie-José T H Goumans; Rudolf A De Boer; Purvesh Khatri; Marlene Rabinovitch; Rolf M F Berger; Beatrijs Bartelds
Journal:  Sci Transl Med       Date:  2020-07-29       Impact factor: 17.956

2.  Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension.

Authors:  Diederik E van der Feen; Michel Weij; Annemieke Smit-van Oosten; Lysanne M Jorna; Quint A J Hagdorn; Beatrijs Bartelds; Rolf M F Berger
Journal:  J Vis Exp       Date:  2017-02-11       Impact factor: 1.355

Review 3.  Metformin as a protective agent against natural or chemical toxicities: a comprehensive review on drug repositioning.

Authors:  S E Meshkani; D Mahdian; K Abbaszadeh-Goudarzi; M Abroudi; G Dadashizadeh; J-D Lalau; M E De Broe; H Hosseinzadeh
Journal:  J Endocrinol Invest       Date:  2019-05-16       Impact factor: 4.256

Review 4.  The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.

Authors:  Olivier Boucherat; Vineet Agrawal; Allan Lawrie; Sebastien Bonnet
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

5.  Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline.

Authors:  Francis Lopes Pacagnelli; Ana Karênina Dias de Almeida Sabela; Katashi Okoshi; Thaoan Bruno Mariano; Dijon Henrique Salomé Campos; Robson Francisco Carvalho; Antônio Carlos Cicogna; Luiz Carlo Marques Vanderlei
Journal:  Int J Exp Pathol       Date:  2016-07-01       Impact factor: 1.925

6.  Effects of Copaiba Oil in Peripheral Markers of Oxidative Stress in a Model of Cor Pulmonale in Rats.

Authors:  Cristina Campos; Patrick Turck; Angela Maria Vicente Tavares; Giana Corssac; Denise Lacerda; Alex Araujo; Susana Llesuy; Adriane Bello Klein
Journal:  Arq Bras Cardiol       Date:  2021-12       Impact factor: 2.000

7.  Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.

Authors:  Wei-Chun Huang; Meng-Wei Ke; Chin-Chang Cheng; Shih-Hwa Chiou; Shue-Ren Wann; Chih-Wen Shu; Kuan-Rau Chiou; Ching-Jiunn Tseng; Hung-Wei Pan; Guang-Yuan Mar; Chun-Peng Liu
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

8.  Biomechanical and Hemodynamic Measures of Right Ventricular Diastolic Function: Translating Tissue Biomechanics to Clinical Relevance.

Authors:  Sae Jang; Rebecca R Vanderpool; Reza Avazmohammadi; Eugene Lapshin; Timothy N Bachman; Michael Sacks; Marc A Simon
Journal:  J Am Heart Assoc       Date:  2017-09-12       Impact factor: 5.501

9.  Preventive treatment with ginsenoside Rb1 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats and involves store-operated calcium entry inhibition.

Authors:  Rui-Xing Wang; Rui-Lan He; Hai-Xia Jiao; Run-Tian Zhang; Jing-Yi Guo; Xiao-Ru Liu; Long-Xin Gui; Mo-Jun Lin; Zhi-Juan Wu
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

10.  Plexiform Lesions in an Experimental Model of Monocrotalin-Induced Pulmonary Arterial Hypertension.

Authors:  Douglas Mesadri Gewehr; Gabriela Rodrigues Salgueiro; Lucia de Noronha; Fernando Bermudez Kubrusly; Luiz Fernando Kubrusly; Gabriel Antonio Coltro; Paola Cardoso Preto; Andressa de Souza Bertoldi; Heloisa Iacomo Vieira
Journal:  Arq Bras Cardiol       Date:  2020-09       Impact factor: 2.667
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.